RIVANNA Awarded $2.9 Million NIH Grant for Expansion of Accuro 3S Indications to Regional Anesthesia in Emergency Medicine

Charlottesville, VA./ November 2, 2023/ PRNewswire/ – RIVANNA®, developers of world-first, imaging-based medical solutions, announced they received a $2.9 million grant from the National Institutes of Health (NIH). The grant will further the development of Accuro® 3S, designed for image-guided regional anesthesia, to broaden access to opioid-sparing analgesia for hip fracture pain. — Read More…